Proposed Special Review Decision PSRD2020-04, Special Reviews of Pymetrozine and Its Associated End-use Products (French, HTML)
Proposed Special Review Decision PSRD2020-04, Special Reviews of Pymetrozine and Its Associated End-use Products: French HTML file. From Health Canada, updated May 2023. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2023-05-31
Before making a special review decision on pymetrozine, Health Canada will consider all comments received from the public in response to PSRD2020-04. A science-based approach will be applied in making a final decision on pymetrozine. Health Canada will then publish a special review decision document, which will include the decision, the reasons for it, a summary of the comments received on the proposed decision, and Health Canada’s response to these comments.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file